[Hearing screening for high-risk newborns]

Peng-jun Zhao1, Zheng-min Xu, Sheng-hu Wu

  • 1Department of Child Health Care, Xinhua Hospital, Shanghai Second Medical University, Shanghai 200092, China.

Insights

Congenital hearing impairment screening in high-risk newborns is crucial. Regular follow-up testing, ideally around 42 days, improves detection rates for hearing loss.

Area of Science:

  • Neonatal screening
  • Auditory health
  • Congenital disorders

Context:

  • Congenital hearing impairment affects newborns, necessitating early detection.
  • High-risk infants require specialized screening protocols.
  • Current screening methods have varying detection rates.

Purpose:

  • To determine the morbidity of congenital hearing impairment in high-risk newborns.
  • To identify pathogenic factors associated with hearing loss in this population.
  • To evaluate the effectiveness of otoacoustic emission (OAE) and auditory brainstem response (ABR) screening.

Summary:

  • A study screened 208 high-risk newborns using OAE, with 130 undergoing a second OAE and ABR. Initial and second screening positive rates were 34.61% and 7.14%, respectively. Two newborns were diagnosed with hearing impairment, a prevalence of 1.78%.
  • Factors like sex, age, and Apgar score influenced initial screening outcomes.
  • The optimal time for initial hearing screening is around 42 days postpartum, with continued monitoring for high-risk infants.

Impact:

  • Establishes optimal timing for neonatal hearing screening.
  • Highlights the need for ongoing surveillance in high-risk infants.
  • Recommends establishing dedicated follow-up systems for early detection and management of hearing impairment.
Abstract

Related Concept Videos